Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
DEEP READ
Ukraine
access_time 16 Aug 2023 11:16 AM IST
Espionage in the UK
access_time 13 Jun 2025 10:20 PM IST
Yet another air tragedy
access_time 13 Jun 2025 9:45 AM IST
exit_to_app
Homechevron_rightIndiachevron_rightNLEM revised: Centre...

NLEM revised: Centre slashes prices of 39 vital drugs

text_fields
bookmark_border
NLEM revised: Centre slashes prices of 39 vital drugs
cancel

New Delhi: Providing relief to patients, the central government has revised the 'National List of Essential Medicines' (NLEM) and slashed the prices of about 39 commonly used drugs.

The prices were slashed for the anti-cancer, anti-diabetes, antiviral, antibacterial, antiretroviral, anti-TB drugs, and also for some medicines that are used in Covid treatment. The experts working on the NLEM list have deleted 16 odd drugs from the list.

The Indian Council of Medical Research (ICMR) has been working for a long time to extend price control on medicines.

The commonly used drugs, which were brought under the price cap includes Teneligliptin -- an anti-diabetes drug, popular anti-TB drugs, Ivermectin -- used in Covid treatment, Rotavirus vaccine, among others.

The government had begun an exercise for the revision of the NLEM, which was notified in 2015 and implemented in 2016.

The Standing National Committee on Medicines was tasked with preparing the list of which medicines should be available in adequate numbers and assured quantity.

The committee headed by Balram Bhargava, Secretary in the Department of Health Research and Director General of the ICMR, send the list to a second committee comprising senior officials from NITI Aayog, Health Secretary and Secretary in the Department of Pharmaceuticals, which decides on which drugs are to be put under the price cap.

The 39 new drugs include Amikacin (antibiotic), Azacitidine (anti-cancer), Bedaquiline (anti-TB), Bendamustine Hydrochloride (anti-cancer), Buprenorphine ( opioid antagonists), Buprenorphine+Naloxone (opioid antagonists), Cefuroxime (antibiotic), Dabigatran (anticoagulant), Daclatasvir (antiviral), Darunavir+Ritonavir (antiretroviral), Delamanid (anti-TB), Dolutegravir (antiretroviral), Fludarabine (anti-cancer), Fludrocortisone (corticosteroid), Fulvestrant (anti-cancer), Insulin Glargine (anti-diabetes), Irinotecan HCL Trihydrate (anti-cancer).

The deleted drugs from the NLEM list are Alteplase (clot buster), Atenolol (anti-hypertension), Bleaching Powder, Cetrimide (antiseptic), Erythromycin (antibiotic), Ethinylestradiol+Norethisterone (birth control), Ganciclovir (antiviral), Lamivudine+Nevirapine+Stavudine (antiretroviral), Leflunomide (antirheumatic), Nicotinamide (Vitamin-B) among a few others, said the Ministry.


Show Full Article
TAGS:NLEMprice revision
Next Story